newsfilter
← Latest News
Business Wire·

Imago BioSciences, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares

Imago BioSciences, Inc. ("Imago") (NASDAQ:IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced that in connection with its previously announced public offer